ATAI
Price
$5.17
Change
-$0.32 (-5.83%)
Updated
Sep 25 closing price
Capitalization
1.21B
53 days until earnings call
XOMAO
Price
$25.55
Change
-$0.10 (-0.39%)
Updated
Sep 25, 02:26 PM (EDT)
Capitalization
N/A
Interact to see
Advertisement

ATAI vs XOMAO

Header iconATAI vs XOMAO Comparison
Open Charts ATAI vs XOMAOBanner chart's image
ATAI Life Sciences
Price$5.17
Change-$0.32 (-5.83%)
Volume$5.65M
Capitalization1.21B
XOMA
Price$25.55
Change-$0.10 (-0.39%)
Volume$290
CapitalizationN/A
ATAI vs XOMAO Comparison Chart in %
Loading...
ATAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XOMAO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATAI vs. XOMAO commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATAI is a StrongBuy and XOMAO is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (ATAI: $5.17 vs. XOMAO: $25.55)
Brand notoriety: ATAI and XOMAO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATAI: 90% vs. XOMAO: 23%
Market capitalization -- ATAI: $1.21B vs. XOMAO: $0
ATAI [@Biotechnology] is valued at $1.21B. XOMAO’s [@Biotechnology] market capitalization is $0. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATAI’s FA Score shows that 1 FA rating(s) are green whileXOMAO’s FA Score has 1 green FA rating(s).

  • ATAI’s FA Score: 1 green, 4 red.
  • XOMAO’s FA Score: 1 green, 4 red.
According to our system of comparison, ATAI is a better buy in the long-term than XOMAO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATAI’s TA Score shows that 4 TA indicator(s) are bullish while XOMAO’s TA Score has 4 bullish TA indicator(s).

  • ATAI’s TA Score: 4 bullish, 4 bearish.
  • XOMAO’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, XOMAO is a better buy in the short-term than ATAI.

Price Growth

ATAI (@Biotechnology) experienced а +9.53% price change this week, while XOMAO (@Biotechnology) price change was -0.51% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.01%. For the same industry, the average monthly price growth was +9.06%, and the average quarterly price growth was +48.80%.

Reported Earning Dates

ATAI is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+1.01% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATAI YTD gains are higher at: 288.722 vs. XOMAO (5.948). XOMAO has higher annual earnings (EBITDA): -305K vs. ATAI (-115.96M). ATAI has more cash in the bank: 95.9M vs. XOMAO (83.9M). ATAI has less debt than XOMAO: ATAI (9.22M) vs XOMAO (115M). XOMAO has higher revenues than ATAI: XOMAO (12.8M) vs ATAI (2.31M).
ATAIXOMAOATAI / XOMAO
Capitalization1.21BN/A-
EBITDA-115.96M-305K38,019%
Gain YTD288.7225.9484,854%
P/E RatioN/AN/A-
Revenue2.31M12.8M18%
Total Cash95.9M83.9M114%
Total Debt9.22M115M8%
FUNDAMENTALS RATINGS
ATAI: Fundamental Ratings
ATAI
OUTLOOK RATING
1..100
19
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
PROFIT vs RISK RATING
1..100
80
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
13
SEASONALITY SCORE
1..100
87

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATAIXOMAO
RSI
ODDS (%)
Bearish Trend 2 days ago
88%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
22%
Momentum
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
21%
MACD
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
30%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
20%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
17%
Advances
ODDS (%)
Bullish Trend 7 days ago
82%
Bullish Trend 8 days ago
21%
Declines
ODDS (%)
Bearish Trend 15 days ago
85%
Bearish Trend 2 days ago
23%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
8%
Aroon
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
17%
View a ticker or compare two or three
Interact to see
Advertisement
ATAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XOMAO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OBSOX28.09N/A
N/A
Oberweis Small-Cap Opportunities
DIAYX30.83N/A
N/A
Diamond Hill Long-Short Y
NQGCX41.20N/A
N/A
Nuveen Global Equity Income C
FIDGX34.48N/A
N/A
Fidelity Advisor Small Cap Growth Z
WWICX12.60N/A
N/A
Westwood Income Opportunity C

XOMAO and

Correlation & Price change

A.I.dvisor indicates that over the last year, XOMAO has been closely correlated with AMLX. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if XOMAO jumps, then AMLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XOMAO
1D Price
Change %
XOMAO100%
-0.41%
AMLX - XOMAO
68%
Closely correlated
-0.43%
NRSN - XOMAO
26%
Poorly correlated
-4.84%
NEVPF - XOMAO
24%
Poorly correlated
N/A
ATAI - XOMAO
24%
Poorly correlated
-5.83%
LTRN - XOMAO
23%
Poorly correlated
-5.46%
More